-- Merger to Create a Sustainable Biotechnology Company: Brings Together Significant Product Assets, Unique Discovery Capabilities and Financial Resources - CAMBRIDGE, Mass. & VANCOUVER, British ...
MUNICH & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Brainlab SE (Brainlab), a digital medical technology company automating and optimizing clinical workflows using artificial intelligence and ...
Snke, a pioneering health tech company, and Precision NeuroMed (PNM), a clinical-stage biotechnology company advancing precision therapeutics for central nervous system (CNS) diseases, announced a ...
An exclusive out-licensing deal could be worth up to $475 million to Neuromed Pharmaceuticals Ltd., which entered an agreement with Merck & Co. Inc. on N-type calcium channel blockers for pain and ...
Merck & Co’s bid to fill the gap in its painkiller portfolio left by the withdrawal of Vioxx has suffered a setback as the firm and partner Neuromed Pharmaceuticals decided to halt development of NMED ...
Vancouver's Neuromed Pharmaceuticals Ltd. has signed a $30 million licensing deal for the exclusive U.S. rights to market a chronic pain drug developed by ALZA Corp., a California-based subsidiary of ...
Under the terms of the merger agreement, CombinatoRx is expected to issue approximately 36 million new shares of its common stock to Neuromed stockholders with each party owning approximately 50% of ...
MUNICH & REDWOOD CITY, Calif., June 10, 2026--(BUSINESS WIRE)--Snke, a pioneering health tech company, and Precision NeuroMed (PNM), a clinical-stage biotechnology company advancing precision ...
-- Merger to Create a Sustainable Biotechnology Company: Brings Together Significant Product Assets, Unique Discovery Capabilities and Financial Resources - CAMBRIDGE, Mass. & VANCOUVER, British ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results